Multiple Manufacturers

GRANISETRON HCL

Manufacturer:

Multiple Manufacturers

Granisetron Hcl HCPCS:

J1626

HCPCS Code Descriptor:

Injection, granisetron hydrochloride, 100 mcg

Category:

J Code

Granisetron Hcl NDCs:

63323-0318-01, 67457-0863-01, 67457-0864-04, 63323-0319-04, 00143-9744-10, 63323-0317-01, 00143-9745-05

Primary Type:

Oncology-Anti-Emetic

Generic/Specialty Status:

Multi-Source

Package Type:

Vial

Route of Administration:

Intravenous

Potential NDC Listing Errors:

Our team has identified potential listing errors/discrepancies with the following NDCs:

00143-9744-10, 63323-0317-01, 00143-9745-05

About Granisetron Hcl:

GRANISETRON HCL is a medication manufactured by multiple manufacturers and aligned to the J Code: J1626. GRANISETRON HCL is administered via the intravenous route of administration.

ACCESS PRICING AND MORE BY REGISTERING

J1626 Added Date:

January 1, 1998

J1626 Effective Date:

January 1, 2009

J1626 Termination Date:

HCPCS Active

We have not yet identified a manufacturer source of Granisetron Hcl billing and coding information.
Our team did not identify a source for Granisetron Hcl patient assistance information. Please reach out to our team if you feel that this is a mistake.
GRANISETRON HCL prescribing information can be found at the link below. Please reach out to us if you believe this information to be innacurate or out of date.
Our team has not yet identified a source of side effects information for GRANISETRON HCL. Please check back in a few weeks.